))
77 Life sciences is not just drugs with Savvas Neophytou and Ben Carter of Deepbridge
Manage episode 365355377 series 3320023
Content provided by Brian Moretta, Hardman & Co and Brian Moretta. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brian Moretta, Hardman & Co and Brian Moretta or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Healthcare is a large industry and is a lot more than just drugs. We have two experts, Savvas Neophytou and Ben Carter of Deepbridge, to discuss the industry and how there is a lot of other life science areas that are attractive to venture capital investors.
We talk a lot about devices. We discuss the challenges and benefits of investing in hardware, how they do diligence on technologies and negotiating the regulatory environment, especially how different areas of the health system can be attractive. We also talk about internationalisation, how markets and regulation interact and how the US doesn't always having the most attractive RoI.
AI is flavour of the month and clearly will have a strong effect on healthcare. Savvas and Ben talk about where we are and how it will progress in the near future.
Links
Deepbridge website - https://www.deepbridgecapital.com/
Deepbridge contact - Andrew Aldridge andrew.aldridge@deepbridgecapital.com
Subscribe to the EIS Navigator podcast on most services here: https://the-eis-navigator.captivate.fm/listen
Suggested books
Tools of Titans by Tim Ferris
Gifted Greek by Moneteagle Stearns
Bios
Dr. Savvas Neophytou
Partner & Chief Investment Officer
Savvas is Chief Investment Officer at Deepbridge. Prior to joining Deepbridge, Savvas enjoyed a 15 year career in the City, working as an investment banker at JP Morgan, Bear Stearns, Shore Capital, Cantor Fitzgerald, and Panmure Gordon. Savvas was also CEO of telemedicine business Now Healthcare Group. As a highly acclaimed analyst, Savvas has won multiple awards, most recently in 2015 when Savvas was ranked 2nd overall in the prestigious Reuters Starmine survey, a position he also held in 2014. In the same year, Savvas was also runner-up in the CityAM Analyst of the Year awards. Savvas holds a PhD in psychopharmacology from Nottingham University and a BSc (Hons) degree in pharmacology from Manchester University.
Ben Carter
Investment Director - Head Of Life Sciences
Ben is the Head of Life Sciences at Deepbridge. Prior to this role, Ben had been the managing director of Touchpoint Service and commercial director of Telmenow the healthcare equipment focussed e-commerce platform. Ben has also been chief commercial officer at Now Healthcare Group, a leading telemedicine provider with its Dr Now app.
With a BA (Hons) in Management from the University of Manchester, Ben’s other corporate experience includes being commercial director at Possum, market leaders in the provision, installation and support of many types of electronic assistive technology.
111 episodes
Share
